Diffusion-weighted MRI for initial staging in Hodgkin`s lymphoma: comparison with FDG PET

Eur J Radiol. 2020 Feb:123:108775. doi: 10.1016/j.ejrad.2019.108775. Epub 2019 Dec 11.

Abstract

Purpose: To evaluate the use of diffusion-weighted MRI (DWI) for initial staging of Hodgkin`s lymphoma and compare it to FDG PET.

Methods: Forty-one patients with Hodgkin`s lymphoma (14 f, 27 m, median age 39 y) were included in this retrospective study. All patients underwent FDG PET/MR for initial staging, including DWI. The Lugano classification was used to describe disease extent. A combination of follow-up imaging and histopathology served as the reference standard. Method agreement was assessed using weighted kappa (κ). The accuracy of the imaging methods was evaluated using ROC curve analysis.

Results: Regarding the Lugano stage, DWI and FDG PET had identical results in 34/41 cases (κ = 0.77). Sensitivity and specificity for nodal involvement was 89.9% and 93.8% for DWI, and 93.8% and 86.9% for FDG PET, respectively. In regard to extranodal involvement, sensitivity and specificity were 88.5% and 99.3% for DWI and 92.3% and 92.7% for FDG PET. The accuracy of both methods for nodal (p = 0.06) and extranodal involvement (p = 0.66) did not differ significantly.

Conclusion: Despite high sensitivity and specificity, DWI in free breathing cannot be currently recommended as an alternative to FDG PET in initial staging of Hodgkin`s lymphoma due to substantial differences in regard to therapy-determining Lugano Stage.

Keywords: FDG PET; Hodgkin`s disease; diffusion-weighted MRI; lymphoma.

MeSH terms

  • Aged
  • Diffusion Magnetic Resonance Imaging* / methods
  • Fluorodeoxyglucose F18
  • Hodgkin Disease / diagnostic imaging*
  • Hodgkin Disease / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Neoplasm Staging / instrumentation*
  • Positron-Emission Tomography / methods
  • Retrospective Studies
  • Sensitivity and Specificity

Substances

  • Fluorodeoxyglucose F18